MedPath
HSA Approval

DAFLON FILM-COATED TABLET 1000 mg

SIN15669P

DAFLON FILM-COATED TABLET 1000 mg

DAFLON FILM-COATED TABLET 1000 mg

April 16, 2019

SERVIER (S) PTE LTD

SERVIER (S) PTE LTD

Regulatory Information

SERVIER (S) PTE LTD

SERVIER (S) PTE LTD

Therapeutic

General Sale List

Formulation Information

TABLET, FILM COATED

**Dosage and method of administration** 3 tablets daily (in 3 divided doses) for 3 to 4 days, then 2 tablets daily (in 2 divided doses).

ORAL

Medical Information

**Therapeutic indications** Treatment of acute hemorrhoidal attacks.

**Contraindications** Do not take Daflon® 1000 if you are allergic (hypersensitive) to micronized purified flavonoid fraction or any of the other ingredients.

C05CA53

diosmin, combinations

Manufacturer Information

SERVIER (S) PTE LTD

LES LABORATORIES SERVIER INDUSTRIE

Active Ingredients

DIOSMIN (MICRONIZED)

900 mg

Diosmin

HESPERIDIN (MICRONIZED)

100 mg

Hesperidin

Documents

Patient Information Leaflets

Daflon tablet 1000mg PIL.pdf

Approved: August 16, 2019

Download
© Copyright 2025. All Rights Reserved by MedPath